Advertisement

Pädiatrie

, Volume 31, Issue 2, pp 28–33 | Cite as

Morbus Crohn und Colitis ulcerosa

Hauterscheinungen bei CED

  • Leo Richter
  • Klemens Rappersberger
Fortbildung
  • 9 Downloads

Morbus Crohn (MC) und Colitis ulcerosa (CU) gelten als Systemerkrankungen und sind nicht selten mit extraintestinalen Manifestationen verbunden, vor allem spielen das Hautorgan und hautnahe Schleimhäute eine besonders wichtige Rolle. Das Zusammentreffen beziehungsweise das gleichzeitige Auftreten verschiedener Erkrankungen stellt oft eine diagnostische und therapeutische Herausforderung dar.

Literatur

  1. 1.
    Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM (2011) Frequency and risk factors for extraintestinal manifestations in the swiss inflammatory bowel disease cohort. Am J Gastroenterol 106(1):110–119CrossRefGoogle Scholar
  2. 2.
    Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20(46):17463–17467CrossRefGoogle Scholar
  3. 3.
    Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11(46):7227–7236CrossRefGoogle Scholar
  4. 4.
    Thrash B, Patel M, Shah KR, Boland CR, Menter A (2013) Cutaneous manifestations of gastrointestinal disease: Part II. J Am Acad Dermatol 68(2):211.e1–211.33 (quiz 244–6)CrossRefGoogle Scholar
  5. 5.
    Tavarela Veloso F (2004) Review article: skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):50–53CrossRefGoogle Scholar
  6. 6.
    Muhvić-Urek M, Tomac-Stojmenović M, Mijandrušić-Sinčić B (2016) Oral pathology in inflammatory bowel disease. World J Gastroenterol 22(25):5655–5667CrossRefGoogle Scholar
  7. 7.
    Lang N, Hartschuh W, Enk A, Toberer F (2015) Metastatic Crohn’s disease: a diagnostic and therapeutic challenge. J Dtsch Dermatol Ges 13(6):571–574PubMedGoogle Scholar
  8. 8.
    Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K (2008) Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases. Medicine (Baltimore) 87(5):281–293CrossRefGoogle Scholar
  9. 9.
    Veloso FT (2011) Extraintestinal manifestations of inflammatory bowel disease: Do they influence treatment and outcome? World J Gastroenterol 17(22):2702–2707CrossRefGoogle Scholar
  10. 10.
    Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, Odes S, Palm Ø, Småstuen M, Moum B, EC-IBD Study Group (2015) Extraintestinal manifestations in Crohn’s disease and ulcerative colitis: results from a prospective, population-based European inception cohort. Scand J Gastroenterol 50(3):300–305CrossRefGoogle Scholar
  11. 11.
    Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri SP, Garcia MS, Maverakis E (2015) Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol 95(5):525–531CrossRefGoogle Scholar
  12. 12.
    Fritsch P (2009) Dermatologie und Venerologie für das Studium. Springer, Berlin, S 746CrossRefGoogle Scholar
  13. 13.
    Topaloğlu Demir F, Kocatürk E, Yorulmaz E, Adalı G, Kavala M (2014) Mucocutaneous manifestations of inflammatory bowel disease in turkey. J Cutan Med Surg 18(6):397–404CrossRefGoogle Scholar
  14. 14.
    Gürkan A, Özlü SG, Altıaylık-Özer P, Kurtul BE, Karacan CD, Şenel S (2015) Recurrent aphthous stomatitis in childhood and adolescence: A single-center experience. Pediatr Dermatol 32(4):476–480CrossRefGoogle Scholar
  15. 15.
    Slebioda Z, Szponar E, Kowalska A (2014) Etiopathogenesis of recurrent aphthous stomatitis and the role of immunologic aspects: literature review. Arch Immunol Ther Exp (Warsz) 62(3):205–215CrossRefGoogle Scholar
  16. 16.
    Jemec GB, Kimball AB (2015) Hidradenitis suppurativa: Epidemiology and scope of the problem. J Am Acad Dermatol 73(5):4–7CrossRefGoogle Scholar
  17. 17.
    Principi M, Cassano N, Contaldo A, Iannone A, Losurdo G, Barone M, Mastrolonardo M, Vena GA, Ierardi E, Di Leo A (2016) Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association. World J Gastroenterol 22(20):4802–4811CrossRefGoogle Scholar
  18. 18.
    Kohorst JJ, Kimball AB, Davis MD (2015) Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol 73(5):S27–S35CrossRefGoogle Scholar
  19. 19.
    Ytting H, Vind I, Bang D, Munkholm P (2005) Sweet’s Syndrome — An extraintestinal manifestation in inflammatory bowel disease. Digestion 72(2–3):195–200CrossRefGoogle Scholar
  20. 20.
    Amouri M, Masmoudi A, Ammar M, Boudaya S, Khabir A, Boudawara T, Turki H (2016) Sweet’s syndrome: a retrospective study of 90 cases from a tertiary care center. Int J Dermatol 55(9):1033–1039CrossRefGoogle Scholar
  21. 21.
    Cohen PR (2007) Sweet’s syndrome — a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 26(2):34CrossRefGoogle Scholar
  22. 22.
    Hundorfean G, Neurath MF, Sitaru C (2010) Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 14(10):2393–2403CrossRefGoogle Scholar
  23. 23.
    Chen M, O’Toole EA, Sanghavi J, Mahmud N, Kelleher D, Weir D, Fairley JA, Woodley DT (2002) The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn’s disease have autoantibodies to type VII collagen. J Invest Dermatol 118(6):1059–1064CrossRefGoogle Scholar
  24. 24.
    Shipman AR, Reddy H, Wojnarowska F (2012) Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review. Clin Exp Dermatol 37(5):461–468CrossRefGoogle Scholar
  25. 25.
    Sobolewska-Włodarczyk A, Włodarczyk M, Fichna J, Wiśniewska-Jarosińska M (2016) Alopecia areata in patients with inflammatory bowel disease: an overview. Folia Med Cracov 56(1):5–12PubMedGoogle Scholar
  26. 26.
    Gill L, Zarbo A, Isedeh P, Jacobsen G, Lim HW, Hamzavi I (2016) Comorbid autoimmune diseases in patients with vitiligo: a cross-sectional study. J Am Acad Dermatol 74(2):295–302CrossRefGoogle Scholar
  27. 27.
    Li WQ, Han JL, Chan AT, Qureshi AA (2013) Psoriasis, psoriatic arthritis and increased risk of incident Crohn’s disease in US women. Ann Rheum Dis 72(7):1200–1205CrossRefGoogle Scholar
  28. 28.
    Fu Y, Lee CH, Chi CC. Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. JAMA Dermatol 2018;154(12):1417–1423CrossRefGoogle Scholar
  29. 29.
    Cohen AD, Dreiher J, Birkenfeld S (2009) Psoriasis associated with ulcerative colitis and Crohn’s disease. J Eur Acad Dermatol Venereol 23(5):561–565CrossRefGoogle Scholar
  30. 30.
    Tsai TF, Wang TS, Hung ST, Tsai PI, Schenkel B, Zhang M, Tang CH (2011) Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan. J Dermatol Sci 63(1):40–46CrossRefGoogle Scholar
  31. 31.
    Burisch J, Jess T, Egeberg A. Incidence of Immune-mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark. Clin Gastroenterol Hepatol 2019. pii: S1542-3565(19)30305-2Google Scholar
  32. 32.
    McCarthy FP (1949) Pyostomatitis vegetans; report of three cases. Arch Derm Syphilol 60(5, Pt. 1):750–764CrossRefGoogle Scholar
  33. 33.
    Femiano F, Lanza A, Buonaiuto C, Perillo L, Dell’Ermo A, Cirillo N (2009) Pyostomatitis vegetans: A review of the literature. Med Oral Patol Oral Cir Bucal 14(3):E114–E117PubMedGoogle Scholar
  34. 34.
    Truchuelo MT, Alcántara J, Vano-Galván S, Jaén P, Moreno C (2013) Bowel-associated dermatosis-arthritis syndrome: another cutaneous manifestation of inflammatory intestinal disease. Int J Dermatol 52(12):1596–1598CrossRefGoogle Scholar
  35. 35.
    DeFilippis EM, Magro C, Jorizzo JL (2014) Bowel-associated dermatosis-arthritis syndrome in a patient with ulcerative colitis: an extraintestinal manifestation of inflammatory bowel disease. Clin J Gastroenterol 7(5):410–413CrossRefGoogle Scholar
  36. 36.
    Monshi B, Stockinger T, Vigl K, Richter L, Weihsengruber F, Rappersberger K (2015) Phrynoderma and acquirded acrodermatitis enteropathica in breastfeeding women after bariatric surgery. J Dtsch Dermatol Ges 13(11):1147–1154PubMedGoogle Scholar
  37. 37.
    von Felbert V, Hunziker T (2010) Acrodermatitis enteropathica-like skin lesions due to Crohn’s disease-associated zinc deficiency. Hautarzt 61(11):927–929CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Authors and Affiliations

  • Leo Richter
    • 1
    • 2
  • Klemens Rappersberger
    • 3
  1. 1.Abteilung für Dermatologie und VenerologieKrankenanstalt RudolfstiftungWienÖsterreich
  2. 2.WienÖsterreich
  3. 3.

Personalised recommendations